| Assay Method Information | |
| | Inhibition Assay |
| Description: | The inventors have assumed that inhibition of nocturnal activity of placental leucine aminopeptidase (P-LAP), i.e. aminopeptidase that cleaves AVP, would maintain and/or increase an endogenous AVP level to enhance the antidiuretic effect, which would contribute to a decreased number of nocturnal voids, and have extensively studied compounds which inhibit P-LAP. |
| Affinity data for this assay | |
|---|---|
| If you find an error in this entry please send us an E-mail | |